SCHEMBL26112587

SCHEMBL26112587

COc1cc2nc[nH]c(=O)c2nc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.52
ADORA3 P0DMS8 1/20 0.40
ALDH1A1 P00352 4/20 0.40
PARP1 P09874 4/20 0.40
HPGD P15428 2/20 0.37
KDM4E B2RXH2 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PDPK1 O15530 2/20 0.37
EGFR P00533 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
XDH P47989 1/20 0.37
PGK1 P00558 1/20 0.36
CHEK1 O14757 1/20 0.36
PIM1 P11309 1/20 0.36
RPS6KA3 P51812 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
ALK Q9UM73 1/20 0.36
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30590825 1.00 SRC (0.52) SRCADORA3ALDH1A1PARP1HPGD
SCHEMBL31352773 0.85 SRC (0.38) SRCADORA3ALDH1A1PARP1HPGD
SCHEMBL26112062 0.85 SRC (0.38) SRCADORA3ALDH1A1PARP1HPGD
SCHEMBL26112568 0.80 PARP1 (0.36) SRCALDH1A1PARP1PDPK1MKNK1
SCHEMBL30590827 0.80 PARP1 (0.36) SRCALDH1A1PARP1PDPK1MKNK1
SCHEMBL30590804 0.79 PARP1 (0.45) ADORA3ALDH1A1PARP1SMN1; SMN2PDPK1
SCHEMBL26112788 0.79 PARP1 (0.45) ADORA3ALDH1A1PARP1SMN1; SMN2PDPK1
SCHEMBL23537901 0.72 ENPP1 (0.50) SRCADORA3ALDH1A1HPGDKDM4E
SCHEMBL8917 0.72 SRC (0.63) SRCALDH1A1PARP1KDM4ESMN1; SMN2
SCHEMBL12247774 0.72 SRC (0.55) SRCALDH1A1PARP1SMN1; SMN2PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025080786-A1 SALT AND SOLID FORMS OF AN EGFR INHIBITOR BLUEPRINT MEDICINES CORPORATION (US) 2025-04-17 WO disclosed
WO-2025080784-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2025-04-17 WO disclosed
EP-4504719-A1 EGFR INHIBITORS Blueprint Medicines Corporation (US) 2025-02-12 EP disclosed
WO-2023196283-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2023-10-12 WO disclosed
WO-2023196283-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2023-10-12 WO disclosed